BRIEF published on 04/30/2025 at 15:32, 1 year 5 months ago Divulgation du groupe Vanguard concernant American Axle & Manufacturing Transactions D'actions Groupe Vanguard Formulaire 8.3 Divulgation Des Valeurs Mobilières Essieu Américain
PRESS RELEASE published on 04/30/2025 at 15:28, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: QUALCOMM Inc The Vanguard Group, Inc. discloses a 10.53% ownership in Qualcomm Inc. through 115,693,243 relevant securities. Public opening position disclosure as per Rule 8.3 of the Takeover Code Securities Disclosure Vanguard Group Ownership Qualcomm Inc.
PRESS RELEASE published on 04/30/2025 at 15:27, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings Inc The Vanguard Group, Inc. discloses 11.21% stake in American Axle & Manufacturing Holdings, Inc. through Form 8.3 filing Form 8.3 Disclosure The Vanguard Group Stake American Axle & Manufacturing Holdings Inc.
BRIEF published on 04/30/2025 at 15:13, 1 year 5 months ago The Vanguard Group's Stake in Mural Oncology plc Ordinary Shares Disclosure The Vanguard Group Stakeholding Mural Oncology
BRIEF published on 04/30/2025 at 15:13, 1 year 5 months ago Participation du groupe Vanguard dans Mural Oncology plc Participation Actions Ordinaires Divulgation Le Groupe Vanguard Oncologie Murale
BRIEF published on 04/30/2025 at 15:11, 1 year 5 months ago Vanguard Discloses Stake in Aviva plc Takeover Code Vanguard Group Stake Disclosure Share Transactions Aviva Plc
BRIEF published on 04/30/2025 at 15:11, 1 year 5 months ago Vanguard révèle sa participation dans Aviva plc Transactions D'actions Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Aviva Plc
BRIEF published on 04/30/2025 at 15:11, 1 year 5 months ago The Vanguard Group Discloses Interest in Dowlais Group plc Takeover Code Vanguard Group Shareholding Stock Disclosure Dowlais Group
BRIEF published on 04/30/2025 at 15:11, 1 year 5 months ago Le groupe Vanguard révèle son intérêt dans Dowlais Group plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Des Stocks Groupe Dowlais
PRESS RELEASE published on 04/30/2025 at 15:08, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 4.47% ownership of Mural Oncology plc's ordinary shares on 29 April 2025 Ordinary Shares The Vanguard Group, Inc. Irish Takeover Panel Ownership Disclosure Mural Oncology Plc
Published on 10/19/2026 at 14:30, 3 hours 37 minutes ago Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 4 hours 7 minutes ago Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 4 hours 37 minutes ago Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 4 hours 37 minutes ago Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 5 hours 6 minutes ago CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Published on 10/19/2026 at 17:45, 22 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:45, 22 minutes ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Published on 10/19/2026 at 17:30, 37 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 19/10/2026
Published on 10/19/2026 at 17:30, 37 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 10/19/2026 (French only)
Published on 10/19/2026 at 17:24, 42 minutes ago Katjes Greenfood places its 2026/2031 bond with a volume of EUR 44 million following significant oversubscription
Published on 10/19/2026 at 18:00, 7 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 7 minutes ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
Published on 10/19/2026 at 17:45, 22 minutes ago Déclaration des transactions sur actions propres réalisées du 12 au 16 octobre 2026 dans le cadre du programme de rachat d’actions
